-->
Hernia repair devices market was valued at US$ 4.69 billion in 2024 and is projected to hit the market valuation of US$ 6.57 billion by 2033 at a CAGR of 4.32% during the forecast period 2025–2033.
Amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, expanding at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
Japan facial injectables market was valued at US$ 508.18 million in 2024 and is projected to hit the market valuation of US$ 1,121.31 million by 2033 at a CAGR of 9.52% during the forecast period 2025–2033.
Elastomeric infusion pumps market was valued at US$ 741.56 million in 2024 and is projected to hit the market valuation of US$ 1,357.40 million by 2033 at a CAGR of 7.85% during the forecast period 2025–2033.
Medical crowdfunding market was valued at US$ 3.47 billion in 2024 and is projected to hit the market valuation of US$ 13.55 billion by 2033 at a CAGR of 16.32% during the forecast period 2025–2033.
The atopic dermatitis therapeutics market is poised for steady growth, with revenues projected to rise from USD 15.43 billion in 2024 to USD 29.5 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.5%.
Medical bioreactor market was valued at US$ 4.31 billion in 2024 and is projected to hit the market valuation of US$ 7.04 billion by 2033 at a CAGR of 5.80% during the forecast period 2025–2033.
Amyloidosis therapeutics market was valued at US$ 2.95 billion in 2024 and is projected to hit the market valuation of US$ 6.37 billion by 2033 at a CAGR of 9.20% during the forecast period 2025–2033.
Compartment syndrome monitoring devices market was valued at US$ 215.93 million in 2024 and is projected to hit the market valuation of US$ 448.48 million by 2033 at a CAGR of 8.46% during the forecast period 2025–2033.